Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126157401 | 12615740 | 1 | I | 20130814 | 20160520 | 20160802 | 20160802 | EXP | US-BAYER-2016-105194 | BAYER | 45.00 | YR | A | M | Y | 0.00000 | 20160802 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126157401 | 12615740 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, QD | N | UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | QD | ||||
| 126157401 | 12615740 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | UNK | N | UNKNOWN | 0 | FILM-COATED TABLET | |||||||
| 126157401 | 12615740 | 3 | SS | XARELTO | RIVAROXABAN | 1 | N | 0 | FILM-COATED TABLET | ||||||||||
| 126157401 | 12615740 | 4 | SS | XARELTO | RIVAROXABAN | 1 | N | 0 | FILM-COATED TABLET | ||||||||||
| 126157401 | 12615740 | 5 | PS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Unknown | 81 MG, QD | 999999 | 81 | MG | QD | |||||||
| 126157401 | 12615740 | 6 | SS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | UNK | 999999 | |||||||||||
| 126157401 | 12615740 | 7 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 75 MG, QD | 0 | 75 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126157401 | 12615740 | 1 | Thrombosis prophylaxis |
| 126157401 | 12615740 | 2 | Atrial fibrillation |
| 126157401 | 12615740 | 3 | Cerebrovascular accident prophylaxis |
| 126157401 | 12615740 | 4 | Thrombosis prophylaxis |
| 126157401 | 12615740 | 5 | Product used for unknown indication |
| 126157401 | 12615740 | 6 | Product used for unknown indication |
| 126157401 | 12615740 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126157401 | 12615740 | OT |
| 126157401 | 12615740 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126157401 | 12615740 | Gastrointestinal haemorrhage | |
| 126157401 | 12615740 | Gingival bleeding | |
| 126157401 | 12615740 | Haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126157401 | 12615740 | 1 | 20120606 | 0 |